Skip to main content

Advertisement

Log in

Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2

Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Common variable immunodeficiency is the most prevalent of the primary immunodeficiency diseases, yet its pathogenesis is largely poorly understood. Of the cases that are monogenic, many arise due to pathogenic variants in NFKB1 and NFKB2. Here, we report enteroviral encephalomyelitis as the cause of a fatal neurodegenerative condition in a patient with a novel heterozygous mutation in NFKB2 (c.2543insG, p.P850Sfs36*) that disrupts non-canonical NF-κB signaling. Investigations of primary and secondary lymphoid tissue demonstrated a complete absence of B cells and germinal centers. Despite multiple negative viral PCR testing of cerebrospinal fluid during her disease progression, post-mortem analysis of cerebral tissue revealed a chronic lymphocytic meningoencephalitis, in the presence of Cocksackie A16 virus, as the cause of death. The clinical features, and progression of disease reported here, demonstrate divergent clinical and immunological phenotypes of individuals within a single family. This is the first reported case of fatal enteroviral encephalomyelitis in a patient with NF-κB2 deficiency and mandates a low threshold for early brain biopsy and the administration of increased immunoglobulin replacement in any patient with a defect in this pathway and deterioration of neurological status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Caamano JH, et al. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med. 1998;187(2):185–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chen K, Coonrod EM, Kumánovics A, Franks ZF, Durtschi JD, Margraf RL, et al. Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet. 2013;93(5):812–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lindsley AW, Qian Y, Valencia CA, Shah K, Zhang K, Assa’ad A. Combined immune deficiency in a patient with a novel NFKB2 mutation. J Clin Immunol. 2014;34(8):910–5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lee CE, Fulcher DA, Whittle B, Chand R, Fewings N, Field M, et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood. 2014;124(19):2964–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Liu Y, Hanson S, Gurugama P, Jones A, Clark B, Ibrahim MAA. Novel NFKB2 mutation in early-onset CVID. J Clin Immunol. 2014;34(6):686–90.

    Article  CAS  PubMed  Google Scholar 

  6. Brue T, Quentien MH, Khetchoumian K, Bensa M, Capo-Chichi JM, Delemer B, et al. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Med Genet. 2014;15:139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency. Medicine. 2016;95(40):e5081.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lougaris V, Tabellini G, Vitali M, Baronio M, Patrizi O, Tampella G, et al. Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease. J Allergy Clin Immunol. 2015;135(6):1641–3.

    Article  CAS  PubMed  Google Scholar 

  9. Kuehn HS, Niemela JE, Sreedhara K, Stoddard JL, Grossman J, Wysocki CA, et al. Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype. Blood. 2017;130(13):1553–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C, et al. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest. 2006;116(11):2964–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fletcher AL, Seach N, Reiseger JJ, Lowen TE, Hammett MV, Scott HS, et al. Reduced thymic Aire expression and abnormal NF-kappa B2 signaling in a model of systemic autoimmunity. J Immunol. 2009;182(5):2690–9.

    Article  CAS  PubMed  Google Scholar 

  12. Bjorses P, et al. Gene defect behind APECED: a new clue to autoimmunity. Hum Mol Genet. 1998;7(10):1547–53.

    Article  CAS  PubMed  Google Scholar 

  13. Ramakrishnan KA, Rae W, Barcenas-Morales G, Gao Y, Pengelly RJ, Patel SV, et al. Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation. J Allergy Clin Immunol. 2018;141(4):1479–1482 e6.

    Article  CAS  PubMed  Google Scholar 

  14. Ameratunga R, Koopmans W, Woon ST, Leung E, Lehnert K, Slade CA, et al. Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clin Transl Immunol. 2017;6(10):e159.

    Article  CAS  Google Scholar 

  15. Fliegauf M, L. Bryant V, Frede N, Slade C, Woon ST, Lehnert K, et al. Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Conley ME, Casanova JL. Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr Opin Immunol. 2014;30:17–23.

    Article  CAS  PubMed  Google Scholar 

  17. Maffucci P, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140(3):782–96.

    Article  CAS  PubMed  Google Scholar 

  19. Nagai M, Imai Y, Yamanishi K. Psoriasiform dermatitis associated with common variable immunodeficiency 10 due to an Arg853* mutation in the NFKB2 gene. J Dermatol. 2019;46(1):e24–6.

    Article  PubMed  Google Scholar 

  20. Gathmann B, Mahlaoui N, CEREDIH, Gérard L, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–26.

    Article  PubMed  Google Scholar 

  21. Schwab C, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932–46.

  22. Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10(2):360–7.

    Article  PubMed  Google Scholar 

  23. Misbah SA, Spickett GP, Ryba PCJ, Hockaday JM, Kroll JS, Sherwood C, et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol. 1992;12(4):266–70.

    Article  CAS  PubMed  Google Scholar 

  24. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987;9(2):334–56.

    Article  PubMed  Google Scholar 

  25. Wilfert CM, Buckley RH, Mohanakumar T, Griffith JF, Katz SL, Whisnant JK, et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977;296(26):1485–9.

    Article  CAS  PubMed  Google Scholar 

  26. Dendle C, Gilbertson M, Korman TM, Golder V, Morand E, Opat S. Disseminated enteroviral infection associated with obinutuzumab. Emerg Infect Dis. 2015;21(9):1661–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Palacios T, Bartelt L, Scheld W, Lopes MB, Kelting SM, Holland S, et al. Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy. Ann Allergy Asthma Immunol. 2015;115(2):148–50.

    Article  PubMed  PubMed Central  Google Scholar 

  28. NaserEddin A, Shamriz O, Keller B, Alzyoud RM, Unger S, Fisch P, et al. Enteroviral infection in a patient with BLNK adaptor protein deficiency. J Clin Immunol. 2015;35(4):356–60.

    Article  CAS  PubMed  Google Scholar 

  29. Mantri S, Shah BB. Enterovirus causes rapidly progressive dementia in a 28-year-old immunosuppressed woman. J Neuro-Oncol. 2016;22(4):538–40.

    Google Scholar 

  30. Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000;13(4):602–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–28.

    Article  CAS  PubMed  Google Scholar 

  32. Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract. 2016;4(6):1059–65.

    Article  PubMed  Google Scholar 

  33. Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol. 2012;157(4):669–79.

    Article  CAS  PubMed  Google Scholar 

  34. Gofshteyn J, Cardenas AM, Bearden D. Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-linked agammaglobulinemia. Pediatr Neurol. 2016;64:94–8.

    Article  PubMed  Google Scholar 

  35. Strating JR, et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep. 2015;10(4):600–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Nguyen JT, et al. Neurologic complications of common variable immunodeficiency. J Clin Immunol. 2016;36(8):793–800.

    Article  CAS  PubMed  Google Scholar 

  37. Akman CI, et al. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol. 2009;51(7):563–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the patients and family for their participation in this study. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646. We also acknowledge the Australian National Health and Medical Research Council (NHMRC, Project Grant 1127198 for VLB; Postgraduate Scholarship 1075666 for CS).We thank Libby Kruse and Sebastian King for critical review of the manuscript.

Funding

VLB is supported by the Victorian State Government Operational Infrastructure Scheme, Holmes Grant Charitable Trust, Rae Grant, Bloody Long Way (BLW), and Walter and Eliza Hall Institute Innovation Grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charlotte A. Slade.

Ethics declarations

Patients and their healthy relatives were recruited from the Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Victoria, Australia. Informed consent was obtained from all individual participants included in the study for genomic analysis and functional immunologic studies prior to inclusion in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of Human Research Ethics Committees at Melbourne Health and The Walter and Eliza Hall Institute for Medical Research (Approved projects 2009.162, 10/02) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Slade, C.A., McLean, C., Scerri, T. et al. Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2. J Clin Immunol 39, 324–335 (2019). https://doi.org/10.1007/s10875-019-00602-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-019-00602-x

Keywords

Navigation